These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 2988552)
1. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors. Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552 [TBL] [Abstract][Full Text] [Related]
2. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats. Jenner P; Rupniak NM; Marsden CD Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009 [TBL] [Abstract][Full Text] [Related]
3. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices. Tedford CE; Crosby G; Iorio LC; Chipkin RE Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318 [TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat. Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370 [TBL] [Abstract][Full Text] [Related]
5. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors. Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043 [TBL] [Abstract][Full Text] [Related]
6. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951 [TBL] [Abstract][Full Text] [Related]
8. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake. Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429 [TBL] [Abstract][Full Text] [Related]
9. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Arnt J; Hyttel J Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689 [TBL] [Abstract][Full Text] [Related]
10. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo. Saller CF; Salama AI J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552 [TBL] [Abstract][Full Text] [Related]
11. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630 [TBL] [Abstract][Full Text] [Related]
12. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats. Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376 [TBL] [Abstract][Full Text] [Related]
13. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952 [TBL] [Abstract][Full Text] [Related]
15. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat. Apud JA; Masotto C; Ongini E; Racagni G Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153 [TBL] [Abstract][Full Text] [Related]
16. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. O'Boyle KM; Waddington JL Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559 [TBL] [Abstract][Full Text] [Related]
17. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation. Chivers JK; Reavill C; Jenner P; Marsden CD J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027 [TBL] [Abstract][Full Text] [Related]
18. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Ogren SO; Hall H; Köhler C; Magnusson O; Sjöstrand SE Psychopharmacology (Berl); 1986; 90(3):287-94. PubMed ID: 2947255 [TBL] [Abstract][Full Text] [Related]
19. Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response? Boireau A; Chambry J; Dubedat P; Farges G; Carruette AM; Zundel JL; Blanchard JC Eur J Pharmacol; 1986 Aug; 128(1-2):93-8. PubMed ID: 2875894 [TBL] [Abstract][Full Text] [Related]
20. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats. Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]